The DEA banned a drug some opioid users called a miracle
Researchers say the Schedule I ban could kill studies of a promising opioid treatment.
Researchers say the Schedule I ban could kill studies of a promising opioid treatment. This story matters for AI & Agent Economy readers tracking web. Reported by arstechnica.com. Read the full original at the source link below.
Originally reported by arstechnica.com. WebNews.net curates and briefs the ai & agent economy stories that matter. Our editorial policy →
Get the daily web signal